AS Grindeks
GRD1R · Nasdaq Riga · Health Care · Pharmaceuticals
Tentang perusahaan
Grindeks is Latvia's largest pharmaceutical manufacturer and one of the leading pharmaceutical companies in the Baltic States. The company develops, produces, and distributes generic medicines and active pharmaceutical ingredients, exporting to over 90 countries. It is best known internationally for developing mildronate, a cardioprotective drug widely used in Eastern Europe and Central Asia.
| Bursa | Nasdaq Riga |
| Kode saham | GRD1R |
| Sektor | Health Care · Pharmaceuticals |
| Kapitalisasi pasar indikatif USD | $90.00M |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (Nasdaq Riga), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Nasdaq Riga, the regulated stock exchange of Latvia operated by Nasdaq, Inc. and part of the Nasdaq Baltic integrated market platform covering Estonia, Latvia, and Lithuania. — pencatatan resmi di bursa
Hanya informasi ketersediaan, bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Latvia
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset, bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.